Combining immune profiling and immunotherapy to tackle human cytomegalovirus infection in transplant patients

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1111306

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The proposed research aims to help transplant patients who are at high risk of cytomegalovirus (CMV) infection, using a treatment called adoptive immunotherapy. I seek to improve the function of patients’ own specialised immune cells (known as T cells) in laboratory and transfer the T cells back into patients, allowing them to better fight the CMV infection. This treatment will improve survival, minimise transplant rejection and reduce the cost associated with anti-viral drugs.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2020

Funding Scheme: Early Career Fellowships

Funding Amount: $314,644.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Transplantation Immunology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

CD8 T lymphocytes | cellular immunity | cytomegalovirus (CMV) infection | pre-clinical studies | transplantation

Related Links